Retrospective analyses incorporating CXCR4-directed ERT in chemotherapy-based conditioning before auto- or alloSCT in hematologic malignancies such as T- and B-cell lymphomas, multiple myeloma and leukemia have confirmed adequate engraftment 33, 38-40. This evidence concerns the gene CXCR4 and hematologic disorder.